IP Library Granted Patent US 12,210,156
Granted Patent B2
US 12,210,156 · App. 17/329,569 · Granted Jan 28, 2025

Wearable image manipulation and control system with high resolution micro-displays and dynamic opacity augmentation in augmented reality glasses

Inventors: Michael Hayes Freeman (Tulsa, OK); Brig. Gen. Richard C. Freeman (Tulsa, OK); Mitchael C. Freeman (Sapulpa, OK); Chad Boss (Tulsa, OK); Jordan Boss (Tulsa, OK); Brian Santee (Tulsa, OK); David Cary (Tulsa, OK)
Assignee: RAYTRX, LLC
G02B27/0172G06F3/013G09G5/003G09G5/377G02B2027/0118G02B2027/0138G09G2354/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,210,156
App. No.
17/329,569
Granted
Jan 28, 2025
Kind
B2
Abstract

A mixed reality display comprising: at least one lens, where the at least one lens has a reflective element, the at least one lens comprising a plurality of pixels; at least one display capable of projecting one or more images onto at least a portion of the at least one lens; and a dynamic opacity system, where the dynamic opacity system is capable of making at least one pixel opaque in the portion of the at least one lens onto which the one or more images are projected, while any portion of the at least one lens onto which no image is projected remains see-through.

Claims (22)

1. An augmented reality system comprising:

a wearable device configured to be worn by a patient including:

a lens subsystem including:

a transparent layer with a first surface and an opposed second surface;

a reflective coating applied to the first surface of the transparent layer; and

an alpha matte layer abutting the second surface of the transparent layer, the alpha matte layer including a cholesteric liquid crystal layer including a plurality of pixels of cholesteric liquid crystal, where each pixel is capable of independently becoming opaque or transparent; and

one or more micro-displays capable of projecting images onto the lens subsystem reflective coating;

a retinal map associated with the patient, where the retinal map comprises at least one boundary indicative of an area to be modified within the patients visual perception;

a display controller in communication with the wearable device capable of receiving and storing the retinal map, capable of receiving a streaming video comprising one or more frames from a camera associated with the patient, capable of buffering the one or more frames of the streaming video, capable of identifying a center of each frame and modifying the streaming video by stretching pixels from the center within the area to be modified within the patient's visual perception to a peripheral area outside the boundary, capable of displaying the modified streaming video onto the lens subsystem reflective coating using the one or more micro-displays, and capable of displaying a plurality of pixels opaque in the portion of the alpha matte layer aligning with the portion of the reflective coating onto which the modified streaming video is projected, while pixels aligning with any portion of the reflective coating onto which no image is projected remains transparent.

2. The augmented reality system of claim 1 where the center of each frame is determined by eye-tracking.

3. The augmented reality system of claim 1 where the display controller buffers the streaming video by mapping each pixel and moving each mapped pixel to a new location.

4. A method of operating an augmented reality wearable device including a lens subsystem, one or more micro-displays capable of projecting images onto the lens subsystem, and a display controller including one or more processors coupled to the lens subsystem and the one or more micro-displays, the lens subsystem including a transparent layer with a first surface and an opposed second surface, a reflective coating applied to the first surface of the transparent layer, and an alpha matte layer abutting the second surface of the transparent layer, the alpha matte layer including a cholesteric liquid crystal layer including a plurality of pixels of cholesteric liquid crystal, where each pixel is capable of independently becoming opaque or transparent, the method comprising the one or more processors executing an algorithm including the steps of:

receiving and storing a retinal map associated with a patient, where the retinal map comprises at least one boundary indicative of an area to be modified within the patient's visual perception;

receiving a streaming video comprising one or more frames from a camera associated with the patient;

modifying the streaming video by:

buffering the one or more frames of the streaming video;

identifying a center of each frame; and

stretching pixels from the center within the area to be modified within the patient's visual perception to a peripheral area outside the boundary;

displaying the modified streaming video onto the lens subsystem reflective coating using the one or more micro-displays; and

displaying a plurality of pixels opaque in the portion of the alpha matte layer aligning with the portion of the reflective coating onto which the modified streaming video is projected, while pixels aligning with any portion of the reflective coating onto which no image is projected remains transparent.

5. The method of claim 4 where the center of each frame is determined by eye-tracking.

6. The method of claim 4 where stretching pixels from the center within the area to be modified within the patient's visual perception to a peripheral area outside the boundary comprises mapping each pixel and moving each mapped pixel to a new location.

Assignments (3)
SECURITY INTEREST Recorded Apr 5, 2024
From: RAYTRX LLC
To: SAGE CONSULTING & WAGE PRESERVATION, INC.
Reel/Frame 067526/0762 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2021
From: FREEMAN, MICHAEL HAYES; FREEMAN (DECEASED), RICHARD C.; FREEMAN, MITCHAEL C.; BOSS (DECEASED), CHAD; BOSS, JORDAN
To: RAYTRX, LLC
Reel/Frame 056342/0697 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2021
From: SANTEE, BRIAN; CARY, DAVID
To: RAYTRX, LLC
Reel/Frame 056342/0741 →
Continuity (10)
Continuation 16511451 · Jul 15, 2019
Continuation 16511202 · Jul 15, 2019
Continuation 16173719 · Oct 29, 2018
Continuation 15962661 · Apr 25, 2018
Continuation 15940561 · Mar 29, 2018
Continuation 15073144 · Mar 17, 2016
Provisional Application 62697854 · Jul 13, 2018
Provisional Application 62489801 · Apr 25, 2017
Provisional Application 62134422 · Mar 17, 2015
Related Publication 20210382312A1 · Dec 9, 2021
References Cited (57)
US 6154321A · Melville · 2000 [cited by examiner]
US 9651786B1 · Browne · 2017 [cited by applicant]
US 10323904B1 · Batten · 2019 [cited by applicant]
US 20020063807A1 · Margulis · 2002 [cited by applicant]
US 20030223038A1 · Alster et al. · 2003 [cited by applicant]
US 20050036109A1 · Blum et al. · 2005 [cited by applicant]
US 20050280603A1 · Aughey et al. · 2005 [cited by applicant]
US 20090218400A1 · Boss et al. · 2009 [cited by applicant]
US 20100011959A1 · Marra · 2010 [cited by applicant]
US 20100149073A1 · Chaum et al. · 2010 [cited by applicant]
US 20120281181A1 · Chen et al. · 2012 [cited by applicant]
US 20130021226A1 · Bell · 2013 [cited by applicant]
US 20130113977A1 · Miao · 2013 [cited by applicant]
US 20130172902A1 · Lightcap et al. · 2013 [cited by applicant]
US 20130215147A1 · Hilkes et al. · 2013 [cited by applicant]
US 20130329190A1 · Lewis et al. · 2013 [cited by applicant]
US 20130335543A1 · Hilkes et al. · 2013 [cited by applicant]
US 20140094655A1 · Newman · 2014 [cited by applicant]
US 20140098226A1 · Pletcher et al. · 2014 [cited by applicant]
US 20140146394A1 · Tout et al. · 2014 [cited by applicant]
US 20140160264A1 · Taylor · 2014 [cited by examiner]
US 20140275760A1 · Lee et al. · 2014 [cited by applicant]
US 20140283429A1 · Sullivan et al. · 2014 [cited by applicant]
US 20140327792A1 · Mulloni et al. · 2014 [cited by applicant]
US 20140372944A1 · Mulcahy et al. · 2014 [cited by applicant]
US 20150193984A1 · Bar-Zeev et al. · 2015 [cited by applicant]
US 20150355481A1 · Hilkes et al. · 2015 [cited by applicant]
US 20160037849A1 · Shearman et al. · 2016 [cited by applicant]
US 20160091968A1 · Angelo et al. · 2016 [cited by applicant]
US 20160247418A1 · Folzenlogen et al. · 2016 [cited by applicant]
US 20160252325A1 · Sammut et al. · 2016 [cited by applicant]
US 20160262608A1 · Krueger · 2016 [cited by applicant]
US 20160270648A1 · Freeman et al. · 2016 [cited by applicant]
US 20160270656A1 · Samec et al. · 2016 [cited by applicant]
US 20170007351A1 · Yu · 2017 [cited by applicant]
US 20170011706A1 · Namkung et al. · 2017 [cited by applicant]
US 20170068119A1 · Antaki et al. · 2017 [cited by applicant]
US 20170094167A1 · Riedel · 2017 [cited by applicant]
US 20170293380A1 · Chauveau et al. · 2017 [cited by applicant]
US 20170323615A1 · Hazra et al. · 2017 [cited by applicant]
US 20180116742A1 · Dell et al. · 2018 [cited by applicant]
US 20180250085A1 · Simi et al. · 2018 [cited by applicant]
US 20190353457A1 · Northrup · 2019 [cited by applicant]
US 20210022599A1 · Freeman et al. · 2021 [cited by applicant]
US 20210149173A1 · Knoblich et al. · 2021 [cited by applicant]
CN 105188516A · 2015 [cited by applicant]
DE 69530170T2 · 2004 [cited by applicant]
EP 4052647 · 2022 [cited by applicant]
JP H09245195 · 1997 [cited by applicant]
JP 2009523563 · 2009 [cited by examiner]
WO 2014140849A2 · 2014 [cited by applicant]
WO 2017094002A1 · 2017 [cited by applicant]
WO 2018057660A2 · 2018 [cited by applicant]
WO 2018057660A3 · 2018 [cited by applicant]
Extended European Search Report in European Patent Application No. 19833423.7; dated Aug. 20, 2022. [cited by applicant]
Office Action received in Chinese Patent Application No. 2018800416969; dated Jan. 12, 2023. [cited by applicant]
European Report in European Patent Application No. 18790963.5; dated Jun. 5, 2023. [cited by applicant]